Suppr超能文献

肌成纤维细胞,在正常和病理组织修复中起主要作用的多种起源。

The myofibroblast, multiple origins for major roles in normal and pathological tissue repair.

作者信息

Micallef Ludovic, Vedrenne Nicolas, Billet Fabrice, Coulomb Bernard, Darby Ian A, Desmoulière Alexis

机构信息

Facultés de Médecine et de Pharmacie, Université de Limoges, EA 6309 "Maintenance Myélinique et Neuropathies Périphériques", FR 3503, Limoges F-87025, France.

Inserm U970, Réparation Artérielle, PARCC-HEGP, Université Paris Descartes, Paris, F-75015, France.

出版信息

Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S5. doi: 10.1186/1755-1536-5-S1-S5. eCollection 2012.

Abstract

Myofibroblasts differentiate, invade and repair injured tissues by secreting and organizing the extracellular matrix and by developing contractile forces. When tissues are damaged, tissue homeostasis must be re-established, and repair mechanisms have to rapidly provide harmonious mechanical tissue organization, a process essentially supported by (myo)fibroblasts. Under physiological conditions, the secretory and contractile activities of myofibroblasts are terminated when the repair is complete (scar formation) but the functionality of the tissue is only rarely perfectly restored. At the end of the normal repair process, myofibroblasts disappear by apoptosis but in pathological situations, myofibroblasts likely remain leading to excessive scarring. Myofibroblasts originate from different precursor cells, the major contribution being from local recruitment of connective tissue fibroblasts. However, local mesenchymal stem cells, bone marrow-derived mesenchymal stem cells and cells derived from an epithelial-mesenchymal transition process, may represent alternative sources of myofibroblasts when local fibroblasts are not able to satisfy the requirement for these cells during repair. These diverse cell types probably contribute to the appearance of myofibroblast subpopulations which show specific biological properties and which are important to understand in order to develop new therapeutic strategies for treatment of fibrotic and scarring diseases.

摘要

肌成纤维细胞通过分泌和组织细胞外基质以及产生收缩力来实现分化、侵入并修复受损组织。当组织受损时,必须重新建立组织内环境稳定,修复机制必须迅速提供协调的机械组织结构,这一过程主要由(肌)成纤维细胞支持。在生理条件下,修复完成(瘢痕形成)时,肌成纤维细胞的分泌和收缩活动终止,但组织功能很少能完全恢复正常。在正常修复过程结束时,肌成纤维细胞通过凋亡消失,但在病理情况下,肌成纤维细胞可能会持续存在,导致过度瘢痕形成。肌成纤维细胞起源于不同的前体细胞,主要来源于结缔组织成纤维细胞的局部募集。然而,当局部成纤维细胞在修复过程中无法满足对这些细胞的需求时,局部间充质干细胞、骨髓来源的间充质干细胞以及上皮-间充质转化过程衍生的细胞,可能是肌成纤维细胞的替代来源。这些不同的细胞类型可能导致了肌成纤维细胞亚群的出现,这些亚群具有特定的生物学特性,为了开发治疗纤维化和瘢痕形成疾病的新治疗策略,了解这些特性很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b60/3368789/4019c5e53ef2/1755-1536-5-S1-S5-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验